Concept Medical launches MAGICAL-SV trial for small-vessel coronary treatment - PNN

Concept Medical Enrolls First Patient in MAGICAL-SV IDE Trial, Expands Coronary Program Globally

Concept Medical initiates MAGICAL-SV IDE trial in the U.S. for its sirolimus-coated balloon, with the first patient enrolled at Mount Sinai. Tampa (Florida) [USA], August 4: Concept Medical Inc., a global pioneer in drug-delivery technologies, today announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions […]

Continue Reading
TRANSFORM II - Global Cardiology Trial Redefining Coronary Care with SCB Technology - PNN News

TRANSFORM II Trial Hits Enrollment Milestone: Redefining Coronary Care with Sirolimus-Coated Balloons

Roughly 80% of patients undergoing percutaneous coronary interventions (PCI) fall into the vessel size category being studied in TRANSFORM II. New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has successfully finished patient enrolment for TRANSFORM II, one of the most ambitious and extensive randomised controlled trials (RCTs) ever carried out in […]

Continue Reading